Best Noxubee County Grants for Nonprofits in Mississippi

About Pfizer Grants

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pre-clinical Investigation of anti-TFPI-mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders

There remains a scientific gap in understanding of the role of anti-TFPImediated hemostatic rebalancing in the context of inherited or non-hemophilic bleeding disorders. This competitive grant program encourages competitive submissions focsed on generating preclinical/foundational data exploring the therapeutic potential and mechanisms of TFPI modulation in bleeding disorders other than hemophilia.

Project Types and Area of Interest

Potential applicants are encouraged to identify and address preclinical/basic science data generation for TFPI modulation/rebalancing in their local setting. This may include:

• Rare bleeding disorders which arise from deficiencies in different clotting factors or pathway components but converge on a common functional endpoint which is an impaired thrombin generation (e.g., Factor II, Factor V, Factor VII, Factor X and Factor XI deficiencies, as well as von Willebrand disease).
• Other diseases such as Glanzmann's thrombasthenia (GT) that have a distinct pathophysiological mechanism.
• Other rare bleeding disorders whose mechanisms are not well understood (e.g., Bleeding Disorder of Unknown Cause, BDUC).

The Novak Family Scholarship

Walter M. Novak was born on April 19, 1921, the second son of Michael and Apolonia, Polish immigrants who had arrived in America just after the turn of the century. They were determined that their two sons receive a college education and through years of hard work in Hoquiam mills, survival through the Great Depression, and with help from their large vegetable garden, fishing, and clamming they were able to send both sons to the University of Washington where they each received Mechanical Engineering degrees.

Walter has inspired many people throughout his life with his dedicated work ethic, intelligence, honesty, concern and care for his employees and friends and his love for his family. He is the true product of the “American Dream” and these scholarships given in his name are meant to help others achieve their goals.

Dr. John D. “Jack” Ehrhart Memorial Scholarship

Dr. John D. Ehrhart was a standout athlete in tennis, football, and basketball who graduated from Hoquiam High School in 1935 and went on to study at Stanford University and earn his M.D. degree from Stanford Medical School.

In high school, Jack won the Pacific Northwest Junior Tennis Championship, and in later years he was instrumental in helping young people learn to play tennis. He remained an avid sports fan all his life. He practiced medicine in Aberdeen for nearly 30 years before his life was cut tragically short in 1974 when the plane he was piloting through dense fog crashed in the hills of East Aberdeen.

The Dr. John D. “Jack” Ehrhart Memorial Scholarship is open to all applicants who satisfy the general eligibility requirements of the Scholarship Program

Dr. George H. Hitchings Memorial Scholarship

Born in Hoquiam in 1905, George H. Hitchings grew up in a family of shipbuilders. Hitchings’ father, George, Sr., worked at and eventually managed the Hoquiam shipyard that his father-in-law, Peter Matthews, established in 1897. 

From the late 1960s until his death in 1998, Dr. Hitchings became increasingly involved with philanthropy. He served as President of the Burroughs Wellcome Fund, a nonprofit foundation which supports biomedical research, and he led several charities in the Research Triangle Park area of North Carolina, where Burroughs Wellcome had relocated in 1968. In 1983, Dr. Hitchings founded the Greater Triangle Community Foundation, which serves the Triangle area.

While preference will be given to applicants interested in studying science or medicine, the George H. Hitchings Memorial Scholarship is open to all applicants who satisfy the general eligibility requirements of the Scholarship Program.

Dave Dupont Memorial Scholarship

The family remembers Dave as a very kind hearted, loving husband, father, and friend. He and his wife Sandi were married 35 years, and had 2 children Kyle and Danielle DuPont.

Dave loved to give back to his community, and attend as many fundraisers as he could. Dave would be proud to be able to give back to the kids in his community.

About Pfizer Grants

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Biochemical and Molecular Characterization of Marstacimab and TFPI Pathways 

This competitive grant encompasses research aimed at elucidating molecular and cellular mechanisms underlying marstacimab-TFPI interactions, including but not limited to differential expression of tissue factor and TFPI in various tissues, binding kinetics, and other biochemical properties. Projects should seek to advance foundational understanding of these interactions through innovative approaches in biochemistry, molecular biology, and related disciplines.

Project Types and Area of Interest

Projects that will be considered for Pfizer support will focus on basic science and fundamental biological understanding of Tissue Factor Pathway Inhibitor (TFPI), anti-TFPI Monoclonal Antibodies, and marstacimab. The areas of interest may include (but are not limited to):

• Basic biology of TFPI including interactions among key regulatory proteins in the intrinsic and/or extrinsic clotting cascades (e.g. Protein S being a co-factor for both Protein C and TFPI).
• Impact of differential TFPI expression within tissues and the role of various TFPI pools/isoforms in the regulation of coagulation.
• Pharmacology resulting from concomitant therapies added to anti-TFPI

The Therapeutic Giving: Oncology program by Johnson & Johnson focuses on funding initiatives that enhance patient access to treatments and services, promote health equity, and strengthen healthcare workforces. It supports programs that raise disease awareness, empower patients, and improve health systems with measurable outcomes. Eligible applicants include nonprofit organizations with 501(c)(3) status, emphasizing innovative programs addressing healthcare disparities and unmet needs.

The Therapeutic Giving program from Johnson & Johnson Innovative Medicine aims to support local and regional organizations focused on improving patient access to treatment and advancing health equity. Eligible applicants include 501(c)(3) nonprofit organizations, with funding preferences for programs that address significant healthcare disparities, mental health initiatives, and innovative solutions with measurable outcomes. The application period for local organizations runs from March 1 to May 31, while national organizations can apply in September.

The Therapeutic Giving initiative by Johnson & Johnson focuses on funding programs in neuroscience aimed at enhancing patient access to treatments and promoting health equity. Nonprofit organizations classified as 501(c)(3) can apply for support from March 1 to May 31. The initiative emphasizes innovative, measurable programs in areas like Alzheimer’s disease and mental health, prioritizing those that address healthcare disparities and improve quality of life for affected individuals.

The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award supports investigator-initiated clinical trials of natural products, including botanicals and dietary supplements. This funding opportunity aims to validate the pharmacokinetics and bioavailability of these products over three years in a phased approach. Successful trials will provide crucial data for further development and clinical application, emphasizing the importance of scientifically driven research in natural product efficacy.

The NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) promotes innovative clinical trials on natural products, such as botanicals and dietary supplements. This funding opportunity supports studies that demonstrate significant scientific rationale and preliminary evidence for efficacy. Applications can explore various delivery methods and combinations with existing treatments to enhance outcomes. Funding is available for up to three years, aimed at bridging basic science discoveries into practical clinical applications.

The NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) invites applications for mid-phase clinical trials involving natural products like botanicals and dietary supplements. The goal is to advance clinical testing through robust preliminary data, ensuring these products demonstrate measurable impacts on target engagement. Submission deadlines span from March 2024 to October 2026. Applications must focus on optimizing doses and identifying patient responders to inform future efficacy trials, aligning with NCCIH's research priorities.

The American Society for the Prevention of Cruelty to Animals (ASPCA) Open Access Publishing Fund Grant supports research that enhances animal welfare. This grant covers article processing fees for open access, peer-reviewed publications up to $5,000. Eligible applicants include U.S. citizens, residents, and researchers in animal welfare. The fund prioritizes submissions in areas such as cruelty prevention, animal sheltering, and veterinary care access, promoting impactful and innovative research.

The NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award aims to support underrepresented graduate students in neuroscience. This two-phase program facilitates the completion of doctoral dissertations and transitions students to postdoctoral positions, enhancing their career development and fostering their growth into independent neuroscience researchers. Applications are due by 5:00 PM local time of the applicant's organization.

The American Veterinary Medical Foundation (AVMF) Veterinary Pharmacology Fellowship Grant supports graduate students pursuing careers in veterinary pharmacology research. Funded in collaboration with the Veterinary Pharmacology Research Foundation, this grant offers up to $10,000 for a one-year fellowship. It covers expenses related to training, professional travel, stipends, and scholarly activities, aiming to enhance the number and quality of skilled researchers in the field.

The Edmond M. Dewan Young Scientist Scholarship for Atmospheric Sciences and Space Physics supports graduate students tackling challenges in atmospheric science and space physics. Funded by the Edmond M. Dewan Young Scientist Scholarship Fund, this scholarship encourages innovative research. Eligible applicants are active AGU student members pursuing graduate studies with a minimum GPA of 3.4. While scholarship recipients do not automatically receive travel grants for AGU’s Annual Meeting, they are encouraged to apply for them separately.

The Horton PhD Research Grant supports up to three Ph.D. students annually in hydrology and related fields, funded by the Robert E. Horton Fund. It provides a maximum of $10,000 for research and travel, along with $500 for U.S. and Canadian applicants participating in AGU's annual meeting. Eligible students must be active AGU members, enrolled for the award's duration, and meet all application requirements. This grant promotes excellence in hydrological sciences.

The American Geophysical Union Jerome M. Paros Scholarship Award supports graduate students pursuing geophysical instrumentation and precise field measurements in seismology, atmospheric sciences, or ocean sciences. Established by Jerome M. Paros, the scholarship awards up to $5,000 to three students annually, fostering talent in this critical field. Eligibility includes being a graduate student at an accredited institution, with a focus on geophysical measurements. AGU student members are encouraged to apply.

The June Bacon-Bercey Scholarship in Atmospheric Sciences for Women supports women pursuing careers in atmospheric sciences and meteorology. Established in 1978 and reintroduced in 2021, it offers a $1,000 scholarship, mentorship opportunities, and networking through AccuWeather. Eligible applicants must identify as women and belong to underrepresented groups in STEM, including Black, Indigenous, and LGBTQ+ individuals, and must be graduate or undergraduate students in relevant programs.

The Lawrence A. Taylor Research Fund in Petrology and Geochemistry offers financial support to two PhD students demonstrating outstanding research in Petrology and/or Geochemistry. Funded by Dong-Hwa Shin (Dawn) Taylor, this grant aims to alleviate some financial burdens associated with their doctoral studies, fostering excellence in these critical fields. Eligible candidates must be AGU student members currently enrolled in relevant doctoral programs and engaged in applicable research.

The Encompass Health Therapy Grant offers up to $50,000 for research on the effectiveness of therapies in inpatient rehabilitation facilities. This funding aims to enhance understanding of neurological impairments and improve patient outcomes through evidence-based practices. Eligible projects must be conducted in the U.S. or Puerto Rico, require a defined research protocol, and adhere to ethical standards. The grant prioritizes studies on therapy impact, implementation science, and caregiver education, contributing to the advancement of rehabilitation care.

The AHRQ Small Health Services Research Grant Program (R03) invites applications for health services research focused on enhancing healthcare quality and patient safety. This funding opportunity supports diverse research settings, including hospitals and home healthcare. Projects may involve collaboration with various stakeholders such as patients, clinicians, and policymakers. By addressing AHRQ research priorities, this initiative aims to improve healthcare delivery and practice while promoting effective partnerships across the healthcare spectrum.

The AHRQ Health Services Research Projects (R01) aims to fund innovative health services research that aligns with AHRQ's priorities, such as enhancing healthcare quality and safety. This initiative encourages applications from various healthcare settings including hospitals and home care, promoting collaboration among diverse stakeholders like patients and policymakers. By addressing key areas of healthcare delivery improvement, this funding opportunity seeks to foster advancements in patient care and overall health system performance.

The National MS Society's Institutional Clinician Training Award supports the training of neurologists and physiatrists in comprehensive MS care. This program enhances the skills of postdoctoral fellows through mentorship and specialized training, ensuring they are equipped to provide personalized, high-quality care. The Society aims to foster a community of leaders in MS clinical practice, encouraging active participation in research and volunteer opportunities to improve outcomes for individuals with MS.

The Multiple Sclerosis Clinical Care Physician Fellowship is a one-year program by the National Multiple Sclerosis Society aimed at training neurologists and physiatrists in specialized clinical care for MS patients. Eligible candidates include PGY3 or PGY4 residents from U.S. programs. The fellowship focuses on supervised patient care, multidisciplinary team activities, and professional development, preparing fellows to provide high-quality care and to engage as future leaders in the MS community.

The Multiple Sclerosis Clinical Care Physician Fellowship: Pediatric Care, offered by the National Multiple Sclerosis Society, aims to enhance the training of physicians in providing specialized care for pediatric patients with MS. This one-year post-residency program emphasizes direct patient care and multidisciplinary collaboration. Participants will learn under the supervision of MS specialists, gaining essential skills to improve clinical practices and contribute to the MS community, ultimately leading to better outcomes for those affected by this condition.

The MRFBC Young Investigator Team Award supports innovative research in immuno-oncology for melanoma, offering up to $150,000 annually for two years. This funding targets U.S.-based researchers aiming to enhance clinical outcomes for melanoma patients or deepen the scientific understanding of immuno-oncology. The MRF collaborates with key institutions to address challenges in melanoma research, fostering partnerships that maximize research potential and impact.